Acer Therapeutics Inc 's

• ACER's Stock Performance relative to its Competitors

Biomarin Pharmaceutical Inc Share Performance +11.93% This Year

Biomarin Pharmaceutical Inc Profile Biomarin Pharmaceutical Inc operates as a biotechnology company, specializing in the development and commercialization of innovative therapies for rare genetic diseases. Their business model revolves around conducting extensive research and development to identify and address unmet medical needs, manufacturing and marketing their approved products, and collaborating with strategic partners to maximize the reach and impact of their therapies worldwide. By focusing on rare diseases, Biomarin leverages their expertise to provide targeted and innovative treatments, ultimately improving the lives of patients in need. More about Biomarin Pharmaceutical Inc's Market Share

Immuron Limited Share Performance +22.13% 30 Days

Immuron Limited Profile Immuron Limited's business model involves the development and commercialization of oral immunotherapeutics that target and treat various diseases. More about Immuron Limited's Market Share

Infinity Pharmaceuticals Inc Share Performance -96.19% This Quarter

Infinity Pharmaceuticals Inc Profile Infinity Pharmaceuticals Inc's business model revolves around the discovery, development, and commercialization of innovative therapies for the treatment of challenging diseases, primarily in the field of oncology. More about Infinity Pharmaceuticals Inc 's Market Share

Insmed Inc Share Performance -12.45% One Year

Insmed Inc Profile Insmed Inc operates as a biopharmaceutical company focused on developing novel therapies for serious and rare diseases. The company's business model revolves around discovering, developing, and commercializing innovative therapies to address significant unmet medical needs. Insmed Inc's efforts primarily center around leveraging its expertise in biologics and advanced drug delivery technologies to improve the lives of patients with rare pulmonary diseases. More about Insmed Inc's Market Share

Innoviva Inc Share Performance +1.01% 30 Days

Innoviva Inc Profile Innoviva Inc's business model revolves around the development and commercialization of pharmaceutical products. The company primarily focuses on creating strategic collaborations and partnerships with biopharmaceutical companies to advance innovative therapies. Innoviva generates revenue through royalty payments received based on the sales of its partnered products. More about Innoviva Inc 's Market Share

Sources: Acer Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, September 14, 2026 8:16 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Acer Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.